Skip to main content Back to Top

8/15/2002

Lilly Recalls 26 Lots of Methohexital Sodium

Kate Traynor

Eli Lilly & Co. is recalling the company's methohexital sodium for injection product, Brevital sodium, which is distributed by King Pharmaceuticals Inc.

According to an urgent drug-recall notice from Jones Pharma Inc., a subsidiary of King, some vials of Brevital may be broken or cracked or contain small particles. The recall affects 2.5-g and 500-mg formulations of the product with expiration dates of September 2002 through December 2003. The specific lots being recalled are as follows:

ProductLotExpiration Date
Brevital sodium, 2.5 g/20 mL5MT41M
4NF66M
8/1/2003
6/1/2003
Brevital sodium, 500 mg/50 mL
1 vial per package
3MN14M
3MN14N
9/1/2002
9/1/2002
Brevital sodium, 500 mg/50 mL
25 vial per package
3MN33M
3MN33P
3MN34P
3MN34R
3MN34S
3MY48M
3MY48N
3MY48P
4MP65M
4MA84M
4MA84N
4MA84P
4MF88M
4MF88N
4MJ99M
5MP44M
5MP44N
5MU47M
5MU47P
5MU47R
5MN77M
5MN77N
10/1/2002
10/1/2002
10/1/2002
10/1/2002
10/1/2002
11/1/2002
11/1/2002
11/1/2002
9/1/2002
11/1/2002
11/1/2002
11/1/2002
6/1/2003
6/1/2003
7/1/2003
8/1/2003
8/1/2003
12/1/2003
12/1/2003
12/1/2003
10/1/2003
10/1/2003

The recall notice asks pharmacies to check their stock and immediately stop distributing the affected lots of Brevital. Pharmacies that have the affected lots in stock should return the product to The NNC Group (call 800-668-4391 to obtain postage-paid shipping labels). A credit memorandum will be issued to reimburse pharmacies that return the product to NNC.